Reflux oesophagitis in heavy drinkers. Effect of ranitidine and alginate/metoclopramide. 1987

H Tønnesen, and J R Andersen, and P Christoffersen, and N Kaas-Claesson
Department of Medicine, Hvidovre Hospital, Denmark.

Of 1,400 consecutive patients applying to an outpatient clinic for treatment of alcoholism, 477 complained of upper abdominal dyspepsia. After 2 weeks of abstinence, 78 had persisting complaints; of these, 72% had oesophagitis at endoscopy. The 53 patients with oesophagitis as the sole diagnosis were randomized to treatment with either ranitidine or a combination of alginate/antacid chewing tablets and metoclopramide for 6 weeks in a double-blind, double-dummy design. Twenty-five patients left the study during the observation time due to relapse of alcoholism, and were only observed until then. No significant differences were found between the treatment groups concerning the course of symptoms and endoscopic or histological improvement.

UI MeSH Term Description Entries
D008297 Male Males
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004942 Esophagitis, Peptic INFLAMMATION of the ESOPHAGUS that is caused by the reflux of GASTRIC JUICE with contents of the STOMACH and DUODENUM. Esophagitis, Reflux,Esophagitides, Peptic,Esophagitides, Reflux,Peptic Esophagitides,Peptic Esophagitis,Reflux Esophagitides,Reflux Esophagitis
D004945 Esophagoscopy Endoscopic examination, therapy or surgery of the esophagus. Esophagoscopic Surgical Procedures,Surgical Procedures, Esophagoscopic,Esophagoscopic Surgery,Surgery, Esophagoscopic,Esophagoscopic Surgeries,Esophagoscopic Surgical Procedure,Esophagoscopies,Procedure, Esophagoscopic Surgical,Procedures, Esophagoscopic Surgical,Surgeries, Esophagoscopic,Surgical Procedure, Esophagoscopic
D005260 Female Females

Related Publications

H Tønnesen, and J R Andersen, and P Christoffersen, and N Kaas-Claesson
October 1983, Gut,
H Tønnesen, and J R Andersen, and P Christoffersen, and N Kaas-Claesson
October 1974, The Medical journal of Australia,
H Tønnesen, and J R Andersen, and P Christoffersen, and N Kaas-Claesson
January 1989, Clinical and experimental obstetrics & gynecology,
H Tønnesen, and J R Andersen, and P Christoffersen, and N Kaas-Claesson
January 1990, Scandinavian journal of gastroenterology. Supplement,
H Tønnesen, and J R Andersen, and P Christoffersen, and N Kaas-Claesson
May 1986, Scandinavian journal of gastroenterology,
H Tønnesen, and J R Andersen, and P Christoffersen, and N Kaas-Claesson
September 1995, European journal of gastroenterology & hepatology,
H Tønnesen, and J R Andersen, and P Christoffersen, and N Kaas-Claesson
August 1996, Alimentary pharmacology & therapeutics,
H Tønnesen, and J R Andersen, and P Christoffersen, and N Kaas-Claesson
November 1984, Irish medical journal,
H Tønnesen, and J R Andersen, and P Christoffersen, and N Kaas-Claesson
October 1996, Scandinavian journal of gastroenterology,
H Tønnesen, and J R Andersen, and P Christoffersen, and N Kaas-Claesson
October 1992, Alimentary pharmacology & therapeutics,
Copied contents to your clipboard!